ESR1 and breast cancer: Secondly, we evaluated the effect of inecalcitol and palbociclib combination treatment in vivo using an ER+ and a TNBC cell line-derived xenograft mouse model to evaluate the clinical applicability of this combination treatment on the different BC subtypes.